Description
SEMAX
Neuroprotective & Cognitive Research
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH) that has been studied extensively in Russian neuroscience research.
Research has explored Semax in relation to neurotrophic signaling, brain-derived neurotrophic factor (BDNF), neuroprotection, stress responses, and cognitive processes.
Clinical research has investigated neurological applications including stroke recovery and cognitive function, although its regulatory status and evidence base differ substantially from those of approved neurological medications in the United States.
Research Focus: Neuroprotection • BDNF signaling • Cognitive research • Neural plasticity
Research Status: Investigational peptide; regulatory status varies by country.
